Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.

about

CDK9 inhibitors in acute myeloid leukemia.Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.

P2860

Q50318294-EEE85536-28D9-4787-83FE-FD08CD69193A Q50416684-2F56F90D-FCC2-4A95-90C6-9FDCB8408387

P2860

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.

Item

http://www.wikidata.org/entity/Q42176458

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@en

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@nl

type

Item

label

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@en

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@nl

prefLabel

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@en

Disulfiram overcomes bortezomi ...... acute myeloid leukemia cells.

@nl

P1476

Disulfiram overcomes bortezomi ...... d acute myeloid leukemia cells

@en

P2093

David O Azorsa

http://www.w3.org/2001/XMLSchema#string

David W Lee

http://www.w3.org/2001/XMLSchema#string

Oliver B Pepper

http://www.w3.org/2001/XMLSchema#string

Ranjan Bista

http://www.w3.org/2001/XMLSchema#string

Robert J Arceci

http://www.w3.org/2001/XMLSchema#string

P2860

Pediatric AML: From Biology to Clinical Management

Prognosis and management of acute myeloid leukemia in patients with Down syndrome

A cryptic protease couples deubiquitination and degradation by the proteasome.

Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram

The JAMM motif of human deubiquitinase Poh1 is essential for cell viability

The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.

Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism

Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.

The resistance mechanisms of proteasome inhibitor bortezomib.

The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts.

P2888

s13046-017-0493-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-017-0493-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eiman Aleem

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083399658

http://www.w3.org/2001/XMLSchema#string

P698

28143565

http://www.w3.org/2001/XMLSchema#string

P932

5286849

http://www.w3.org/2001/XMLSchema#string

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.

about

P2860

P2860

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932